Authors: Giaquinto C, Green H, De Rossi A, et al. On behalf of the PENTA 8 study group.
Published in: 3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janerio. Oral and poster presentation WeOa0106
Abstract The development of resistance to antiretroviral drugs is considered to be an important cause of treatment failure in HIV infection. Many randomised trials and studies have been conducted to assess the clinical utility of resistance testing in adults, with mixed conclusions. However, current clinical guidelines recommend the routine use of resistance testing as part of patient management.